Re-Emerging C797S in Trans and Rechallenge of Osimertinib With Erlotinib

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.12.015
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Successful Rechallenge With Gefitinib for an Initial Erlotinib-Responder With Advanced Lung Adenocarcinoma

Tuberculosis and Respiratory Diseases
PulmonaryInfectious DiseasesRespiratory Medicine
2011English

Successful Rechallenge With Reduced Dose of Erlotinib in a Patient With Lung Adenocarcinoma Who Developed Erlotinib‑associated Leukocytoclastic Vasculitis: A Case Report

Oncology Letters
Cancer ResearchOncology
2012English

Successful Erlotinib Rechallenge for Leptomeningeal Metastases of Lung Adenocarcinoma After Erlotinib-Induced Interstitial Lung Disease: A Case Report and Review of the Literature

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2012English

Novel SPECC1L-MET Fusion Detected in Circulating Tumor DNA in a Patient With Lung Adenocarcinoma Following Treatment With Erlotinib and Osimertinib

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

C797S and T790M EGFR Mutations in Non–Small Cell Lung Cancer: In Trans or in Separate Clones?

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

PC04.01 Optimal Sequencing of EGFR TKI Therapy (Gefitinib/Erlotinib/Afatinib First Versus Osimertinib First)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The Challenge of Emerging and Re-Emerging Infectious Diseases

Nature
Multidisciplinary
2010English

Patient-Reported Outcomes From FLAURA: Osimertinib Versus Erlotinib or Gefitinib in Patients With EGFR-mutated Advanced Non-Small-Cell Lung Cancer

European Journal of Cancer
Cancer ResearchOncology
2020English

Rechallenge With Checkpoint Inhibitors in Metastatic Melanoma

JDDG - Journal of the German Society of Dermatology
Dermatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy